Associations of renal function with polymorphisms in the δ-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers

Environmental Health Perspectives

Volumn 111, Issue 13, 2003, Pages 1613-1619

  Weaver, Virginia M ^a,b   Schwartz, Brian S ^a,b,c   Ahn, Kyu Dong ^d   Stewart, Walter F ^a,c   Kelsey, Karl T ^e   Todd, Andrew C ^f   Wen, Jiayu ^a   Simon, David J ^c   Lustberg, Mark E ^g   Parsons, Patrick J ^h   Silbergeld, Ellen K ^a   Lee, Byung Kook ^d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Soonchunhyang University   (South Korea)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h WADSWORTH CENTER   (United States)

Author keywords

Endothelial nitric oxide synthase; Genetic susceptibility factors; Lead exposure; N acetyl D glucosaminidase (NAG); Renal function; Retinol binding protein; Vitamin D receptor; aminolevulinic acid dehydratase

Indexed keywords

CHELATING AGENT; CREATININE; LEAD; N ACETYL BETA GLUCOSAMINIDASE; NITRIC OXIDE SYNTHASE; NITROGEN; PORPHOBILINOGEN SYNTHASE; RETINOL BINDING PROTEIN; SUCCIMER; UREA; VITAMIN D RECEPTOR;

ADULT; ALLELE; BONE LEVEL; BONE MINERAL; CHELATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DATA ANALYSIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; HUMAN; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; KOREA; LEAD BLOOD LEVEL; LEAD POISONING; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; ULTRAFILTRATION; UREA NITROGEN BLOOD LEVEL; URINE LEVEL; WORKING TIME;

EID: 0142061007     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.6116     Document Type: Review

References (50)

1. Alexander BH, Checkoway H, Costa-Mallen P, Faustman EM, Woods JS, Kelsey KT, et al. 1998. Interaction of blood lead and δ-aminolevulinic acid dehydratase genotype on markers of home synthesis and sperm production in lead smelter workers. Environ Health Perspect 106:213-216.
2. Allon R. 1990. Renal abnormalities in sickle cell disease. Arch Intern Med 150:501-504.
3. Battistuzzi G, Petrucci R, Silvagni L, Urbani FR, Caiola S. 1981. δ-Aminolevulinate dehydrase: a new genetic polymorphism in man. Ann Hum Genet 45:223-229.
4. Bellinger D, Hu H, Titlebaum L, Needleman HL. 1994. Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health 49:98-105.
5. Bergdahl IA, Gerhardsson L, Schutz A, Desnick RJ, Wetmur JG, Skerfving S. 1997a. Delta-aminolevulinic acid dehydratase polymorphism: influence on lead levels and kidney function in humans. Arch Environ Health 52:91-96.
6. Bergdahl IA, Grubb A, Schutz A, Desnick RJ, Wetmur JG, Sassa S, et al. 1997b. Lead binding to δ-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol 81:153-158.
7. Brenner BM, Lawler EV, Mackenzie HS. 1996. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 49:1774-1777.
8. Cleveland WS. 1979. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74:829-836.
9. Cockcroft DW, Gault MH. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41.
10. Cooper GS, Umbach DM. 1996. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 11:1841-1849.
11. Fleming DEB, Chettle DR, Wetmur JG, Desnick RJ, Robin J-P, Boulay D, et al. 1998. Effect of the δ-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers. Environ Res 77:49-61.
12. Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fujita T, et al. 1998. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 32:521-526.
13. Hu H. 1991. A 50-year follow-up of childhood plumbism. Hypertension, renal function, and hemoglobin levels among survivors. Am J Dis Child 145:681-687.
14. Hu H, Wu M-T, Cheng Y, Sparrow D, Weiss S, Kelsey K. 2001. The δ-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. Environ Health Perspect 109:827-832.
15. Kelada SN, Shelton E, Kaufmann RB, Khoury MJ. 2001. δ-Aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review. Am J Epidemiol 154:1-13.
16. Khalil-Manesh F, Gonick HC, Cohen AH, Alinovi R, Borgamaschi E, Mutti A, et al. 1992. Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int 41:1192-1203.
17. Kim R, Aro A, Rotnitzky A, Amarasiriwardena C, Hu H. 1995. K X-ray fluorescence measurements of bone lead concentration: the analysis of low-level data. Phys Med Biol 40:1475-1485.
18. Klahr S. 2001. The role of nitric oxide in hypertension and renal disease progression. Nephrol Dial Transplant 16:60-62.
19. Kleinbaum DG, Kupper LL, Muller KE, Nizam A. 1998. Applied Regression Analysis and Other Multivariable Methods. 3rd ed. Pacific Grove, CA:Brooks/Cole Publishing Company.
20. Kneip TJ, Crable JV. 1988. Methods for Biological Monitoring: A Manual for Assessing Human Exposure to Hazardous Substances. Washington, DC:American Public Health Association.
21. Lee B-K, Lee G-S, Stewart WF, Ahn K-D, Simon D, Kelsey KT, et al. 2001. Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and δ-aminolevulinic acid dehydratase genes. Environ Health Perspect 109:383-389.
22. Lee S-S, Lee B-K, Lee G-S, Stewart WF, Simon D, Kelsey K, et al. 2001. Associations of load biomarkers and delta-aminolevulinic acid dehydratase and vitamin D receptor genotypes with hematopoietic outcomes in Korean lead workers. Scand J Work Environ Health 27:402-411.
23. Marco MP, Craver L, Betriu A, Fibla J, Fernandez E. 2001. Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients. Am J Kidney Dis 38:965-974.
24. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, et al. 1998. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32:3-8.
25. Muller D, Sievers E, Eggert P. 1999. Influence of hyperfiltration on the measurement of urinary N-acetyl-beta-D-glucosaminidase. Pediatr Nephrol 13:519-523.
26. Nenov VD, Taal MW, Sakharova OV, Brenner BM. 2000. Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hypertens 9:85-97.
27. Noiri E, Satoh H, Taguchi J, Brodsky SV, Nakao A, Ogawa Y, et al. 2002. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 40:535-540.
28. Ozaki Y, Nomura S, Nagahama M, Yoshimura C, Kagawa H, Fukuhara S. 2000. Vitamin-D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus. Nephron 85:86-91.
29. Parsons PJ, Slavin W. 1999. Electrothermal atomization atomic absorption spectrometry for the determination of lead in urine: results of an interlaboratory study. Spectrochim Acta Part B At Spectrosc 54:853-864.
30. Persu A, Stoenoiu MS, Messiaen T, Davila S, Robino C, El-Khattabi O, et al. 2002. Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 11:229-241.
31. Roels H, Lauwerys R, Konings J, Buchet JP, Bernard A, Green S, et al. 1994. Ronal function and hyperfiltration capacity in lead smelter workers with high bone lead. Occup Environ Med 51:505-512.
32. Schwartz BS, Lee BK, Lee GS, Stewart WF, Lee SS, Hwang KY, et al. 2001. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am J Epidemiol 153:453-464.
33. Schwartz BS, Lee B-K, Lee G-S, Stewart WF, Simon D, Kelsey K, et al. 2000a. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and δ-aminolevulinic acid dehydratase genes. Environ Health Perspect 108:949-954.
34. Schwartz BS, Lee B-K, Stewart W, Ahn K-D, Springer K, Kelsey K. 1995. Associations of δ-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol 142:738-745.
35. Schwartz BS, Lee B-K, Stewart W, Sithisarankul P, Strickland PT, Ahn K-D, et al. 1997. δ-Aminolevulinic acid dehydratase genotype modifies 4-hour urinary lead excretion after oral administration of dimercaptosuccinic acid. Occup Environ Med 54:241-246.
36. Schwartz BS, Stewart WF, Kelsey KT, Simon D, Park S, Links JM, et al. 2000b. Associations of tibial lead levels with Bsmil polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ Health Perspect 108:199-203.
37. Schwartz BS, Stewart WF, Todd AC, Links JM. 1999. Predictors of dimercaptosuccinic acid chelatable lead and tibial lead in former organolead manufacturing workers. Occup Environ Med 56:22-29.
38. Sithisarankul P, Schwartz BS, Lee B-K, Kelsey KT, Strickland PT. 1997. Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers. Am J Ind Med 32:15-20.
39. Smith CM, Wang X, Hu H, Kelsey KT. 1995. A polymorphism in the δ-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect 103:248-253.
40. 109Cd 'spot' source. Basic Life Sci 60:299-302.
41. 109Cd sources: radiation dosimetry studies. Environ Res 57:117-132.
42. Topping MD, Forster HW, Dolman C, Luczynska CM, Bernard AM. 1986. Measurement of urinary retinol-binding protein by enzyme-linked immunosorbent assay, and its application to detection of tubular proteinuria. Clin Chem 32:1863-1866.
43. Vaziri ND, Ding Y, Ni Z, Gonick HC. 1997. Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapy. Kidney Int 52:1042-1046.
44. Weaver VM, Buckley T, Groopman JD. 2000. Lack of specificity of trans,trans-muconic acid as a benzene biomarker after ingestion of sorbic acid-preserved foods. Cancer Epidemiol Biomark Prev 9:749-755.
45. Weaver VM, Lee B-K, Lee G-S, Ahn KD, Lee G-S, Todd AC, et al. 2003. Associations of lead biomarkers with renal function in Korean lead workers. Occup Environ Med 60:551-562.
46. Weisberg S. 1985. Applied Linear Regression. New York:John Wiley & Sons.
47. Wetmur JG, Lehnert G, Desnick RJ. 1991. The δ-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res 56:109-119.
48. Yuen CT, Kind PRN, Price RG, Praill PF, Richardson AC. 1984. Colorimetric assay for N-acetyl-β-D-glucosaminidase (NAG) in pathological urine using the ω-nitrostyryl substrate: the development of a kit and the comparison of manual procedure with the automated fluorimetric method. Ann Clin Biochem 21:295-300.
49. Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS. 2000. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 57:405-413.
50. Ziemsen B, Angerer J, Lehnert G, Benkmann HG, Goedde HW. 1986. Polymorphism of delta-aminolevulinic acid dehydratase in lead-exposed workers. Int Arch Occup Environ Health 58:245-247.